Cradle is a Dutch–Swiss biotechnology software company founded in 2021 with headquarters in Amsterdam and an office in Zurich, building an AI-powered protein engineering platform for industrial biotech and biopharma R&D teams. The platform combines proprietary generative AI models — trained on billions of natural protein sequences and on data produced in Cradle's own Amsterdam wet lab — with a web application and REST API/Python SDK so that scientists can design, simulate, and co-optimize amino-acid sequence variants across multiple measurable properties such as activity, binding affinity, stability, expression, and developability. Core platform capabilities include AI candidate generation, multi-property co-optimization, virtual plate design, experimental data management with full versioning and audit trails, task orchestration (analyze data, diversify, engineer, select, search, train) across modalities including antibodies/mAbs, enzymes, vaccines, therapeutic peptides, and food ingredients, plus a Custom Predictors framework letting customers plug in their own ML models. Cradle is sold as enterprise SaaS to R&D organizations — disclosed customers and partners include Johnson & Johnson Janssen, Bayer, Novozymes/Novonesis, and Twist Bioscience, with the platform serving six of the top 25 global pharma companies and over 50 active R&D programs. The company has raised approximately $115M to date across a seed round (Index Ventures, 2022), a $24M Series A (Index Ventures, 2023), and a $73M Series B (IVP, 2024). Co-founders are Stef van Grieken (CEO), Jelle Prins, Elise de Reus, Eli Bixby, and Harmen van Rossum.
Cradle publishes 1 API on the APIs.io network. Tagged areas include Protein Engineering, Generative Biology, Generative AI, Foundation Models, and Machine Learning.
Cradle’s developer surface includes documentation, API reference, SDKs, engineering blog, and 15 more developer resources.
The Cradle Platform API is an enterprise REST API for programmatic access to Cradle's AI-driven protein engineering platform. It is organized under per-workspace v2 endpoints an...
aid: cradle-bio
name: Cradle
description: >-
Cradle is a Dutch–Swiss biotechnology software company founded in 2021
with headquarters in Amsterdam and an office in Zurich, building an
AI-powered protein engineering platform for industrial biotech and
biopharma R&D teams. The platform combines proprietary generative AI
models — trained on billions of natural protein sequences and on data
produced in Cradle's own Amsterdam wet lab — with a web application and
REST API/Python SDK so that scientists can design, simulate, and
co-optimize amino-acid sequence variants across multiple measurable
properties such as activity, binding affinity, stability, expression,
and developability. Core platform capabilities include AI candidate
generation, multi-property co-optimization, virtual plate design,
experimental data management with full versioning and audit trails,
task orchestration (analyze data, diversify, engineer, select, search,
train) across modalities including antibodies/mAbs, enzymes, vaccines,
therapeutic peptides, and food ingredients, plus a Custom Predictors
framework letting customers plug in their own ML models. Cradle is sold
as enterprise SaaS to R&D organizations — disclosed customers and
partners include Johnson & Johnson Janssen, Bayer, Novozymes/Novonesis,
and Twist Bioscience, with the platform serving six of the top 25
global pharma companies and over 50 active R&D programs. The company
has raised approximately $115M to date across a seed round (Index
Ventures, 2022), a $24M Series A (Index Ventures, 2023), and a $73M
Series B (IVP, 2024). Co-founders are Stef van Grieken (CEO), Jelle
Prins, Elise de Reus, Eli Bixby, and Harmen van Rossum.
type: Index
position: Provider
access: 3rd-Party
image: https://kinlane-productions.s3.amazonaws.com/apis-json/apis-json-logo.jpg
tags:
- Protein Engineering
- Generative Biology
- Generative AI
- Foundation Models
- Machine Learning
- Biotechnology
- Biopharma
- Drug Discovery
- Antibody Discovery
- Enzyme Engineering
- Vaccines
- Therapeutic Peptides
- Industrial Biotech
- Synthetic Biology
- Computational Biology
- Wet Lab
- Life Sciences
- Custom Predictors
url: https://raw.githubusercontent.com/api-evangelist/cradle-bio/refs/heads/main/apis.yml
created: '2026-05-25'
modified: '2026-05-25'
specificationVersion: '0.20'
apis:
- aid: cradle-bio:cradle-platform-api
name: Cradle Platform API
tags:
- Protein Engineering
- Workspaces
- Projects
- Rounds
- Data Management
- Tables
- Data Loads
- Artifacts
- Tasks
- Audit Logs
- Custom Predictors
humanURL: https://docs.cradle.bio/api/
baseURL: https://app.cradle.bio/v2
properties:
- type: Documentation
url: https://docs.cradle.bio/api/
- type: GettingStarted
url: https://docs.cradle.bio/docs/getting-started/overview/
- type: SDK
url: https://docs.cradle.bio/sdk/cradle/sdk/
- type: PythonSDKPackage
url: https://pypi.org/project/cradle-sdk/
- type: CustomPredictorTemplate
url: https://github.com/cradlebio/custom-predictor-template
- type: SignIn
url: https://app.cradle.bio
description: >-
The Cradle Platform API is an enterprise REST API for programmatic
access to Cradle's AI-driven protein engineering platform. It is
organized under per-workspace v2 endpoints and exposes resource
groups for Workspaces, Projects, Rounds, Data Management, Tables,
Data Loads (file upload/download with finalize, undo, and redo),
Artifacts, Tasks, Audit Logs, and Custom Predictors. Task creation
endpoints (analyze-data/v2, diversify/v2, engineer/v2, select/v2,
search/v2, train/v2) drive Cradle's core generative protein
workflows — sequence diversification, multi-property
co-optimization, candidate selection, similarity search, and
model fine-tuning — and return artifacts that can be inspected,
pulled into custom pipelines, or chained into downstream lab
automation. The API is paired with an official Python SDK
(`cradle-sdk` on PyPI) and a Custom Predictor framework that lets
customers register internally developed models against the same
orchestration surface used by the Cradle web application. Access
is enterprise-gated (no public self-serve tier); authentication
and SSO are handled at the workspace level with SOC 2 controls,
and the spec is rendered as ReDoc-based reference rather than
published as a downloadable OpenAPI file.
common:
- type: Website
url: https://www.cradle.bio
- type: Platform
url: https://www.cradle.bio/platform
- type: Application
url: https://app.cradle.bio
- type: Documentation
url: https://docs.cradle.bio
- type: APIReference
url: https://docs.cradle.bio/api/
- type: SDK
url: https://docs.cradle.bio/sdk/cradle/sdk/
- type: Blog
url: https://www.cradle.bio/blog
- type: Careers
url: https://www.cradle.bio/careers
- type: Security
url: https://www.cradle.bio/security
- type: PyPIPackage
url: https://pypi.org/project/cradle-sdk/
- type: GitHubOrganization
url: https://github.com/cradlebio
- type: BoltzModel
url: https://github.com/cradlebio/boltz
- type: CustomPredictorTemplate
url: https://github.com/cradlebio/custom-predictor-template
- type: Bioutils
url: https://github.com/cradlebio/bioutils
- type: LinkedIn
url: https://www.linkedin.com/company/cradlebio
- type: Twitter
url: https://twitter.com/cradlebio
- type: GoogleCloudCaseStudy
url: https://cloud.google.com/customers/cradlebio
- type: BayerPartnership
url: https://www.bayer.com/en/us/news-stories/ai-enabled-antibody-discovery-and-optimization
- type: Wikipedia
url: https://en.wikipedia.org/wiki/Cradle_(company)
maintainers:
- FN: Kin Lane
email: [email protected]